QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online November 18, 2003
doi: 10.1242/10.1242/jcs.00812

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vial, E. Articles by Marshall, C. J. Search for Related Content PubMed PubMed Citation Articles by Vial, E. Articles by Marshall, C. J.

Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells

Cancer Research UK Centre for Cell and Molecular Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK

^* Author for correspondence (e-mail: chris.marshall{at}icr.ac.uk)

Accepted 30 July 2003

The AP-1 (activator protein-1) complex, which consists of proteins of the Fos and Jun families, is thought to play an important role in the balance between cell proliferation and apoptosis, the response to genotoxic stress and cell transformation. In cells containing oncogenic Ras, the major components of AP-1 are Fra-1 and c-Jun. Signalling from Ras to AP-1 is through the Raf/MEK[mitogen-activated protein (MAP) kinase kinase]/ERK (extracellular signal-regulated kinase) MAP kinase pathway as sustained activation of Raf1 or Mek1 modifies AP-1 composition and activity. To analyse the potential link between the ERK-MAPK pathway and AP-1 in colon cancer, in which RAS and BRAF mutations are frequent, we have studied the regulation of AP-1 in colon carcinoma cell lines. We show that c-JUN and FRA-1 expression is dependent on ERK activity and that different thresholds of ERK activity control the expression of FRA-1. A basal activity is required to induce transcription of the FRA-1 gene, but additional higher levels of activity stabilize FRA-1 against proteasome-dependent degradation. These results provide a clear-cut example that the magnitude of ERK signalling affects the cellular response. Although we find no contribution of FRA-1 towards cell proliferation of adherent tumour cells, the high levels of FRA-1 in cells where elevated ERK activity leads to protein stabilization provide survival signals for tumour cells removed from the extracellular matrix.

Key words: ERK-MAPK, AP-1, FRA-1, transcription, degradation, anoïkis

This article has been cited by other articles:

				M. M. Monick, L. S. Powers, C. W. Barrett, S. Hinde, A. Ashare, D. J. Groskreutz, T. Nyunoya, M. Coleman, D. R. Spitz, and G. W. Hunninghake Constitutive ERK MAPK Activity Regulates Macrophage ATP Production and Mitochondrial Integrity J. Immunol., June 1, 2008; 180(11): 7485 - 7496. [Abstract] [Full Text] [PDF]

				J. Basbous, D. Chalbos, R. Hipskind, I. Jariel-Encontre, and M. Piechaczyk Ubiquitin-Independent Proteasomal Degradation of Fra-1 Is Antagonized by Erk1/2 Pathway-Mediated Phosphorylation of a Unique C-Terminal Destabilizer Mol. Cell. Biol., June 1, 2007; 27(11): 3936 - 3950. [Abstract] [Full Text] [PDF]

				H.-J. Cho, J. H. Kang, J.-Y. Kwak, T.-S. Lee, I.-S. Lee, N. G. Park, H. Nakajima, J. Magae, and Y.-C. Chang Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms Carcinogenesis, May 1, 2007; 28(5): 1104 - 1110. [Abstract] [Full Text] [PDF]

				S. Balasubramanian and R. L. Eckert Curcumin Suppresses AP1 Transcription Factor-dependent Differentiation and Activates Apoptosis in Human Epidermal Keratinocytes J. Biol. Chem., March 2, 2007; 282(9): 6707 - 6715. [Abstract] [Full Text] [PDF]

				P. G. Ulery, G. Rudenko, and E. J. Nestler Regulation of {Delta}FosB Stability by Phosphorylation. J. Neurosci., May 10, 2006; 26(19): 5131 - 5142. [Abstract] [Full Text] [PDF]

				Q. Zhang, P. Adiseshaiah, D. V. Kalvakolanu, and S. P. Reddy A Phosphatidylinositol 3-Kinase-regulated Akt-Independent Signaling Promotes Cigarette Smoke-induced FRA-1 Expression J. Biol. Chem., April 14, 2006; 281(15): 10174 - 10181. [Abstract] [Full Text] [PDF]

				K. Kakumoto, K. Sasai, T. Sukezane, C. Oneyama, S. Ishimaru, K. Shibutani, H. Mizushima, E. Mekada, H. Hanafusa, and T. Akagi FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts PNAS, April 4, 2006; 103(14): 5490 - 5495. [Abstract] [Full Text] [PDF]

				K. A. Conrads, M. Yi, K. A. Simpson, D. A. Lucas, C. E. Camalier, L.-R. Yu, T. D. Veenstra, R. M. Stephens, T. P. Conrads, and G. R. Beck Jr. A Combined Proteome and Microarray Investigation of Inorganic Phosphate-induced Pre-osteoblast Cells Mol. Cell. Proteomics, September 1, 2005; 4(9): 1284 - 1296. [Abstract] [Full Text] [PDF]

				K. Macleod, P. Mullen, J. Sewell, G. Rabiasz, S. Lawrie, E. Miller, J. F. Smyth, and S. P. Langdon Altered ErbB Receptor Signaling and Gene Expression in Cisplatin-Resistant Ovarian Cancer Cancer Res., August 1, 2005; 65(15): 6789 - 6800. [Abstract] [Full Text] [PDF]

				M. Ebisuya, K. Kondoh, and E. Nishida The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity J. Cell Sci., July 15, 2005; 118(14): 2997 - 3002. [Abstract] [Full Text] [PDF]

				S. Hong, K.-K. Park, J. Magae, K. Ando, T.-S. Lee, T. K. Kwon, J.-Y. Kwak, C.-H. Kim, and Y.-C. Chang Ascochlorin Inhibits Matrix Metalloproteinase-9 Expression by Suppressing Activator Protein-1-mediated Gene Expression through the ERK1/2 Signaling Pathway: INHIBITORY EFFECTS OF ASCOCHLORIN ON THE INVASION OF RENAL CARCINOMA CELLS J. Biol. Chem., July 1, 2005; 280(26): 25202 - 25209. [Abstract] [Full Text] [PDF]

				A. Pullikuth, E. McKinnon, H.-J. Schaeffer, and A. D. Catling The MEK1 Scaffolding Protein MP1 Regulates Cell Spreading by Integrating PAK1 and Rho Signals Mol. Cell. Biol., June 15, 2005; 25(12): 5119 - 5133. [Abstract] [Full Text] [PDF]

				E. Hoffmann, A. Thiefes, D. Buhrow, O. Dittrich-Breiholz, H. Schneider, K. Resch, and M. Kracht MEK1-dependent Delayed Expression of Fos-related Antigen-1 Counteracts c-Fos and p65 NF-{kappa}B-mediated Interleukin-8 Transcription in Response to Cytokines or Growth Factors J. Biol. Chem., March 11, 2005; 280(10): 9706 - 9718. [Abstract] [Full Text] [PDF]

				C. B. Pollock, S. Shirasawa, T. Sasazuki, W. Kolch, and A. S. Dhillon Oncogenic K-RAS Is Required to Maintain Changes in Cytoskeletal Organization, Adhesion, and Motility in Colon Cancer Cells Cancer Res., February 15, 2005; 65(4): 1244 - 1250. [Abstract] [Full Text] [PDF]

				Q. Zhang, P. Adiseshaiah, and S. P. Reddy Matrix Metalloproteinase/Epidermal Growth Factor Receptor/Mitogen-Activated Protein Kinase Signaling Regulate fra-1 Induction by Cigarette Smoke in Lung Epithelial Cells Am. J. Respir. Cell Mol. Biol., January 1, 2005; 32(1): 72 - 81. [Abstract] [Full Text] [PDF]

				A. Whitehurst, M. H. Cobb, and M. A. White Stimulus-Coupled Spatial Restriction of Extracellular Signal-Regulated Kinase 1/2 Activity Contributes to the Specificity of Signal-Response Pathways Mol. Cell. Biol., December 1, 2004; 24(23): 10145 - 10150. [Abstract] [Full Text] [PDF]